Actor
Gene Signal International SA
Development of innovative therapies for angiogenesis disorders based on a new class of oligonucleotides, proteins and monoclonal antibodies derived from genes exclusively involved in the angiogenesis process.
Specialties
Primary Therapeutic Areas
1.0 Therapeutic & Diagnostic
1.05 Gene Therapy
Business model
1. Entreprise
1.3 SME
Organization Type
Private Company
Visit website
Domains
Dermatology, Oncology, Ophtalomology
Main sector
Services Providers & Consulting
Contact
EPFL Innovation Park Bat A
1015 Lausanne / VD
021 804 61 64